Are genetic vaccines the future for infectious diseases & cancer?

In order to fight infectious diseases and cancer, our immune system has
to face a number of problems, such as immunologic tolerance where immune
suppression is exerted at systemic and local level. Therefore, the
choice of antigens and vaccination technologies need to be exceptionally
potent. A genetic vaccine is made of a DNA fragment which encodes for
an antigen, administered as such (naked DNA) or embedded within an
engineered viral vector.
During the event, the associated technologies’ clinical data obtained
so far, plus the perspectives in this highly innovative biotechnology
field will be discussed. The event will additionally comprise a Takis’
Laboratories tour.


Between 28-30 September 2016, Barakaldo will be the stage for BioSpain, a forum offering all biotechnology actors the opportunity to share knowledge, ideas and experiences about a lot of issues (cosmetics, food, health, energy, …). The event has become the main international platform which showcases Spanish biotechnology and provides answers to the commercial, academic and information needs of the sector.

The cycle of early detection and advanced therapies

2016 is a turning point for orphan drugs and for neonatal screenings. In Europe the benefit of orphan drug designation is debated, whilst in Italy a scientific inclusive environment is pushing for the finalisation of the law extending neonatal screenings. Through deliberative debates, highlights of the newly updated kit-PlayDecide ORPHAN DRUGS, in regions where training and community-building are key to consolidating the cycle of early diagnosis and access to appropriate therapy: patients, caregivers, future parents, students, researchers, health professionals, industry, institutions and communication representatives, analyse these issues of great complexity and high impact on the quality of life together .